sar
coronaviru
sarscov
etiolog
agent
sever
acut
respiratori
syndrom
sar
acut
pulmonari
syndrom
emerg
winter
result
death
approxim
individu
close
infect
drosten
et
al
fouchier
et
al
ksiazek
et
al
kuiken
et
al
despit
concern
sarscov
would
reemerg
last
winter
hand
individu
found
infect
viru
individu
appear
much
less
sever
symptom
secondari
transmiss
observ
liang
et
al
peiri
et
al
song
et
al
sever
case
sar
also
report
result
laboratori
infect
normil
coronaviru
spike
protein
mediat
infect
receptorbear
cell
gallagh
buchmeier
holm
hofmann
pohlmann
angiotensinconvert
enzym
function
receptor
sarscov
bind
sarscov
protein
high
affin
li
et
al
sever
line
evid
suggest
physiolog
relev
receptor
infect
tissu
express
receptor
correspond
local
viru
infect
individu
anim
harmer
et
al
chan
et
al
ding
et
al
ham
et
al
also
effici
infect
human
mice
rat
correl
abil
speci
support
viral
replic
li
et
al
subbarao
et
al
wentworth
et
al
antibodi
block
associ
sui
et
al
protect
mice
infect
sui
et
al
final
although
mani
cell
line
express
cell
line
shown
support
sarscov
infect
replic
detect
express
receptor
hofmann
et
al
nie
et
al
although
dcsignr
lsign
dcsign
recent
shown
enhanc
infect
cell
jeffer
et
al
marzi
et
al
yang
et
al
protein
appear
mediat
effici
infect
absenc
jeffer
et
al
marzi
et
al
unlik
mani
type
fusion
protein
includ
coronavirus
protein
sarscov
cleav
virusproduc
cell
xiao
et
al
moor
et
al
howev
two
domain
correspond
protein
process
coronavirus
defin
gallagh
buchmeier
domain
mediat
receptor
associ
wherea
domain
membraneassoci
like
undergo
structur
rearrang
mediat
membran
fusion
discret
receptorbind
domain
rbd
protein
defin
residu
domain
xiao
et
al
babcock
et
al
wong
et
al
rbd
bind
higher
affin
full
domain
wong
et
al
earli
case
sar
report
occur
anim
trader
restaur
worker
handl
wild
mammal
sarscov
isol
two
mammal
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
guan
et
al
palm
civet
also
implic
minor
sar
outbreak
zhong
sequenc
sprotein
gene
virus
isol
palm
civet
one
raccoon
dog
determin
guan
et
al
song
et
al
interestingli
rbd
anim
protein
highli
conserv
except
residu
vari
asparagin
basic
amino
acid
differ
sever
posit
rbd
virus
isol
outbreak
although
differ
palmcivetderiv
rbd
latter
rbd
highli
conserv
sprotein
gene
obtain
sever
human
outbreak
et
al
zhang
et
al
full
sequenc
also
publish
two
sprotein
gene
obtain
mild
outbreak
et
al
song
et
al
gene
nearli
ident
contain
element
common
protein
isol
earlier
human
outbreak
isol
palm
civet
describ
sproteinbind
domain
human
character
chimera
human
rat
introduc
four
residu
human
rat
convert
receptor
support
littl
sproteinmedi
infect
receptor
bind
domain
support
infect
effici
close
human
character
addit
variant
local
sproteinbind
domain
primarili
loop
lead
show
repres
protein
mild
outbreak
one
palm
civet
mediat
effici
infect
cell
express
palmcivet
compar
cell
express
human
receptor
contrast
protein
sever
outbreak
effici
bind
util
receptor
two
region
sproteinbind
site
two
residu
rbd
protein
larg
determin
differ
data
describ
sprotein
adapt
receptor
counterpart
permit
effici
infect
human
cell
adapt
absolut
conserv
outbreak
may
part
account
unusu
sever
sar
previous
shown
sproteinmedi
infect
cell
express
human
substanti
effici
cell
express
level
rat
li
et
al
first
investig
whether
differ
local
enzymat
collectrin
domain
latter
domain
defin
close
homolog
small
kidneyexpress
protein
name
zhang
et
al
figur
show
fusion
protein
compris
sarscov
domain
fc
domain
human
effici
precipit
human
well
chimera
human
catalyt
domain
rat
collectrin
domain
contrast
could
precipit
rat
chimera
rat
catalyt
domain
human
collectrin
domain
abil
chimer
receptor
bind
also
reflect
abil
support
sproteinmedi
infect
figur
data
indic
differ
abil
rat
human
support
infect
local
catalyt
domain
receptor
guid
structur
catalyt
domain
towler
et
al
made
seri
human
variant
one
solventexpos
residu
alter
rat
counterpart
two
variant
consist
bound
less
effici
wildtyp
human
introduct
rat
residu
nf
includ
glycosyl
site
asparagin
present
human
partial
inhibit
associ
figur
sproteinmedi
entri
figur
alter
lysin
histidin
residu
present
rat
receptor
interf
dramat
associ
also
partial
inhibit
sproteinmedi
entri
introduct
human
residu
myp
lysin
rat
result
substanti
increas
bind
assay
immunoprecipit
flow
cytometri
figur
b
combin
set
residu
result
rat
variant
bound
support
sproteinmedi
infect
compar
human
figur
data
suggest
residu
lysin
particip
sprotein
associ
human
subsequ
alter
number
addit
residu
human
vicin
residu
alanin
case
aspart
acid
alter
two
residu
first
helix
lysin
tyrosin
substanti
interf
associ
residu
adjac
lysin
aspart
acid
arginin
within
figur
figur
show
three
view
crystal
structur
human
residu
convert
rat
effici
sarscov
receptor
shown
red
addit
residu
whose
alter
interfer
associ
shown
yellow
green
indic
residu
whose
alter
affect
bind
ctermin
collectrin
domain
well
order
structur
use
posit
molecul
respect
cell
membran
shown
figur
sproteinbind
site
local
deep
cleft
harbor
catalyt
site
upper
left
structur
view
face
cleft
crystal
structur
solv
two
distinct
conform
open
one
figur
conform
cleft
close
around
inhibitor
dale
et
al
towler
et
al
two
conform
like
reflect
free
substratebound
state
enzym
respect
investig
whether
larg
conform
chang
associ
inhibitor
bind
interf
bind
sproteinmedi
infect
previous
report
inhibit
activ
low
nanomolar
rang
dale
et
al
enzymat
activ
detect
presenc
nm
inhibitor
figur
howev
nm
interfer
immunoprecipit
inhibitor
interfer
sproteinmedi
infect
figur
c
consist
observ
distanc
among
carbon
residu
sproteinbind
site
vari
less
inhibitorbound
unbound
structur
towler
et
al
contrast
distanc
residu
residu
across
cleft
typic
vari
greater
two
structur
data
suggest
sproteinbind
region
perturb
inhibitor
substrat
induc
larg
conform
chang
receptor
consist
studi
also
observ
use
assay
shown
figur
interfer
enzymat
activ
data
shown
protein
use
studi
obtain
patient
infect
sever
sarscov
outbreak
anoth
outbreak
winter
caus
much
less
sever
symptom
individu
infect
result
document
humantohuman
transmiss
et
al
liang
et
al
zhong
song
et
al
compar
protein
viru
isol
latter
outbreak
access
number
denot
gd
herein
viru
obtain
outbreak
isol
palm
civet
guan
et
al
marra
et
al
rota
et
al
et
al
song
et
al
figur
show
domain
three
protein
effici
bound
palmcivet
access
number
wherea
domain
effici
bound
human
note
domain
viru
isol
outbreak
bound
palmcivet
much
effici
bound
human
investig
rbd
sprotein
variant
abil
domain
bind
palmcivet
human
reflect
abil
respect
rbd
bind
receptor
figur
also
assay
abil
entir
protein
mediat
infect
cell
express
human
palmcivet
effici
entri
consist
abil
domain
variant
bind
figur
data
consist
hypothesi
palm
civet
sourc
sarscov
suggest
appar
lack
sever
diseas
outbreak
may
due
part
incomplet
adapt
gd
viru
human
rbd
differ
four
residu
figur
investig
residu
contribut
abil
rbd
bind
effici
human
residu
rbd
alter
counterpart
alter
two
residu
posit
interf
associ
rbd
human
figur
surfac
plasmon
reson
studi
demonstr
greater
decreas
affin
human
either
residu
residu
alter
palmcivet
counterpart
tabl
supplementari
figur
notabl
alter
threonin
serin
also
affect
abil
rbd
associ
palmcivet
figur
introduct
residu
substanti
increas
abil
full
protein
infect
cell
express
human
introduct
residu
posit
protein
result
decreas
infect
cell
figur
data
suggest
adapt
protein
human
facilit
alter
residu
asparagin
threonin
also
investig
determin
civet
particip
abil
facilit
effici
infect
gd
two
region
within
sproteinbind
site
differ
significantli
human
palmcivet
see
figur
e
region
residu
vari
six
residu
human
civet
likewis
loop
initi
differ
four
residu
glycosyl
site
asparagin
human
part
latter
region
present
palmcivet
figur
show
domain
gd
bound
substanti
effici
either
region
introduc
human
introduct
region
result
receptor
bind
compar
wildtyp
palmcivet
observ
also
reproduc
infect
assay
figur
data
demonstr
residu
within
sproteinbind
domain
larg
determin
effici
gd
protein
bind
util
human
palmcivet
figur
compar
abil
eight
rbd
variant
bind
human
civet
well
chimer
molecul
assay
figur
pointmut
variant
palmcivet
aspart
acid
alter
glycin
present
human
rbd
variant
gener
left
panel
right
panel
alter
posit
indic
panel
figur
permit
sever
conclus
first
rough
equival
left
right
panel
indic
impli
figur
c
sprotein
residu
account
differ
rbd
second
consist
differ
observ
palmcivet
variant
glycin
residu
indic
littl
contribut
residu
sprotein
associ
third
consist
infect
data
figur
presenc
threonin
residu
enhanc
affin
rbd
civet
human
variant
receptor
compar
exampl
rbd
variant
variant
abil
precipit
variant
fourth
contrast
substitut
lysin
asparagin
context
increas
abil
rbd
variant
associ
human
palmcivet
compar
bind
rbd
variant
bind
human
lane
palmcivet
lane
likewis
variant
enhanc
also
observ
chimera
contain
human
residu
lane
palm
civet
lane
wherea
residu
determin
sensit
rbd
residu
fifth
consist
infect
data
figur
supplementari
figur
rbd
bound
variant
bear
residu
palmcivet
substanti
effici
bound
equival
variant
human
residu
posit
compar
lane
lane
panel
thu
data
figur
indic
lysin
sprotein
residu
interfer
rbd
associ
human
palmcivet
supplementari
figur
show
data
consist
steric
interact
lysin
human
lysin
protein
data
also
show
alter
sprotein
serin
threonin
increas
rbd
affin
human
civet
final
suggest
protein
studi
fulli
adapt
human
residu
consist
recent
zoonot
transmiss
viru
figur
summar
find
figur
show
aminoacid
sequenc
region
critic
sprotein
associ
palmcivet
rat
human
figur
show
orient
ctermin
membraneassoci
collectrin
domain
face
away
viewer
red
indic
residu
whose
alter
transform
rat
effici
sarscov
receptor
orang
indic
addit
residu
common
rat
human
whose
alter
also
interfer
sprotein
associ
yellow
indic
residu
along
ridg
uniqu
palmcivet
permit
effici
associ
rbd
isol
palm
civet
like
interact
lysin
palmcivet
rbd
human
interfer
palmcivet
rbd
lysin
label
white
text
figur
four
residu
begin
permit
effici
bind
infect
protein
assay
shown
cyan
glycosyl
site
region
present
human
palmcivet
shown
green
function
receptor
sarscov
like
play
critic
role
viral
replic
infect
host
li
et
al
ham
et
al
nie
et
al
describ
sproteinbind
domain
particular
residu
along
first
lysin
proxim
residu
nterminu
particip
sprotein
bind
infect
alter
histidin
rat
modifi
glyosyl
site
may
alter
shape
convert
rat
effici
receptor
sarscov
sproteinbind
region
remain
intact
presenc
inhibitor
dramat
alter
overal
conform
dale
et
al
towler
et
al
consist
inabl
inhibitor
block
infect
inabl
protein
modul
activ
although
multipl
constraint
interspeci
transmiss
virus
webbi
et
al
sprotein
alter
suffici
extend
alter
host
rang
number
coronavirus
kuo
et
al
casai
et
al
haijema
et
al
schickli
et
al
shown
entri
primari
barrier
sarscov
infect
murin
cell
li
et
al
observ
suggest
sprotein
chang
may
critic
suffici
adapt
sarscov
human
cell
accordingli
compar
protein
deriv
outbreak
less
sever
outbreak
gd
appar
healthi
palm
civet
guan
et
al
et
al
strikingli
receptorbind
region
protein
bound
palmcivet
effici
outbreak
bound
human
compar
effici
data
consist
absenc
humantohuman
transmiss
outbreak
recent
transmiss
sarscov
palm
civet
human
guan
et
al
zhong
song
et
al
differ
among
protein
permit
identif
key
chang
necessari
adapt
human
receptor
particular
chang
sprotein
residu
appear
critic
highaffin
associ
human
alter
small
uncharg
residu
consist
properti
describ
sarscov
obtain
human
wherea
civetderiv
virus
retain
basic
residu
posit
guan
et
al
marra
et
al
rota
et
al
et
al
zhang
et
al
song
et
al
data
indic
residu
interact
residu
along
ridg
form
particular
lysin
present
human
palmcivet
alter
sprotein
residu
asparagin
found
viru
isol
human
appear
accommod
human
lysin
differ
sprotein
residu
also
interest
threonin
posit
absolut
conserv
protein
isol
sever
outbreak
contrast
protein
virus
isol
outbreak
anim
sarscov
isol
serin
posit
guan
et
al
et
al
zhang
et
al
song
et
al
threonin
posit
increas
affin
rbd
assay
human
palmcivet
chimera
thereof
substanti
enhanc
effici
palmcivetderiv
protein
infect
cell
express
human
observ
indic
addit
methyl
group
threonin
particip
effici
infect
human
nonhuman
cell
sprotein
alter
residu
import
highaffin
associ
human
effici
infect
cell
express
receptor
knowledg
residu
may
use
assess
risk
pose
new
sarscov
outbreak
data
also
show
even
chang
outsid
rbd
sarscov
imperfectli
adapt
human
receptor
particular
introduct
residu
civet
human
receptor
increas
bind
infect
mediat
protein
assay
effect
may
due
remov
glycosyl
site
posit
sarscov
fulli
adapt
observ
rais
possibl
solubl
human
lack
glycosyl
would
effect
inhibit
sarscov
replic
wildtyp
human
previous
shown
replic
sarscov
murin
cell
line
limit
low
affin
protein
murin
li
et
al
moreov
affin
protein
receptor
rat
mice
human
correl
abil
viru
replic
anim
lower
affin
palmcivetderiv
protein
palmcivet
receptor
consist
pattern
overt
diseas
manifest
anim
viru
isol
guan
et
al
diseas
observ
palm
civet
challeng
isol
obtain
outbreak
wu
et
al
togeth
observ
suggest
affin
protein
import
determin
overal
rate
viral
replic
sever
diseas
adapt
within
protein
critic
highaffin
associ
human
may
contribut
unusu
sever
sar
plasmid
encod
codonoptim
form
sarscov
protein
isol
access
number
previous
describ
li
et
al
moor
et
al
plasmid
encod
correspond
protein
isol
isol
mild
outbreak
access
number
denot
gd
herein
isol
isol
palm
civet
access
number
gener
de
novo
recurs
pcr
plasmid
encod
domain
residu
rbd
residu
protein
fuse
fc
domain
human
rbdig
respect
previous
describ
li
et
al
wong
et
al
correspond
rbdig
variant
gd
isol
variant
molecul
gener
mutagenesi
use
quikchang
method
invitrogen
human
rat
palmcivet
molecul
amplifi
cdna
correspond
tissu
pcr
clone
vector
encod
previous
describ
amino
carboxytermin
tag
li
et
al
associ
rbdig
variant
determin
flow
cytometri
immunoprecipit
flow
cytometri
use
cell
previous
describ
li
et
al
wong
et
al
briefli
cell
transfect
plasmid
encod
variant
vector
alon
day
posttransfect
cell
detach
mm
edta
wash
bsa
rbdig
variant
thereof
antitag
antibodi
ad
cell
mixtur
incub
ice
h
cell
wash
three
time
bsa
incub
min
ice
antihuman
igg
fitc
conjug
sigma
cell
wash
bsa
analyz
immunoprecipit
perform
previous
describ
li
et
al
wong
et
al
briefli
cell
transfect
plasmid
encod
variant
radiolabel
cystein
methionin
day
transfect
cell
harvest
lyse
pb
buffer
contain
chapso
cell
lysat
incub
protein
bead
togeth
rbdig
variant
antibodi
recogn
carboxytermin
tag
recogn
aminotermin
myc
tag
protein
bead
wash
three
time
chapso
analyz
immunoprecipit
variant
quantifi
phosphorimag
rbdig
variant
also
assay
surfac
plasmon
reson
use
biacor
nm
portion
purifi
rbdig
variant
bound
antihuman
antibodi
sigma
immobil
sensor
chip
solubl
human
hbsep
buffer
biacor
introduc
flow
rate
concentr
nm
kinet
paramet
determin
biaevalu
softwar
biacor
mlv
express
gfp
pseudotyp
sarscov
sprotein
variant
previous
describ
moor
et
al
briefli
mlv
virion
gener
cotransfect
plasmid
encod
mlv
gag
pol
gene
pqcxix
vector
bd
scienc
express
gfp
plasmid
encod
sprotein
variant
h
posttransfect
cell
supernat
normal
revers
transcriptas
activ
incub
cell
transfect
variant
h
postincub
gfp
fluoresc
infect
cell
measur
flow
cytometri
case
cell
preincub
h
inhibitor
infect
equival
concentr
maintain
infect
infect
also
assay
lentiviru
express
luciferas
report
gene
pseudotyp
sprotein
variant
previous
describ
sui
et
al
briefli
cell
cotransfect
plasmid
encod
sprotein
variant
plasmid
encod
gagpol
plasmid
phivluc
encod
firefli
luciferas
report
gene
control
long
termin
repeat
day
posttransfect
viral
supernat
harvest
sproteinpseudotyp
viru
use
infect
cell
plate
infect
effici
quantit
measur
luciferas
activ
target
cell
eg
g
berthold
micropl
luminomet
lb
enzymat
activ
assay
use
fluorogen
substrat
trophenyl
oh
r
system
cleavag
peptid
remov
moieti
quench
fluoresc
moieti
portion
solubl
form
moor
et
al
incub
mm
tri
buffer
vari
concentr
inhibitor
dale
et
al
fluoresc
monitor
min
interv
use
excit
wavelength
nm
emiss
wavelength
nm
